Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-233485
Filing Date
2023-09-12
Accepted
2023-09-12 16:21:58
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d515985ddefa14a.htm DEFA14A 20658
2 GRAPHIC g515985g03m00.jpg GRAPHIC 521469
3 GRAPHIC g515985g04m00.jpg GRAPHIC 1014035
  Complete submission text file 0001193125-23-233485.txt   2137043
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

EIN.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36066 | Film No.: 231250339
SIC: 2834 Pharmaceutical Preparations